Cyp2b9 Mouse (1->4)-beta-D-glucan multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CYP2B9 mRNA CTD PMID:36331819 Cyp2b9 Mouse (R,R,R)-alpha-tocopherol decreases expression EXP 6480464 alpha-Tocopherol results in decreased expression of CYP2B9 mRNA CTD PMID:26102010 Cyp2b9 Mouse 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane affects expression EXP 6480464 o and p'-DDT affects the expression of CYP2B9 mRNA CTD PMID:18925944 Cyp2b9 Mouse 2,2',3,3',6,6'-hexachlorobiphenyl increases expression EXP 6480464 2 more ... CTD PMID:28431184 Cyp2b9 Mouse 2,2',4,4',5,5'-hexachlorobiphenyl increases expression EXP 6480464 2 more ... CTD PMID:20005886 and PMID:21851831 Cyp2b9 Mouse 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 [2 more ... CTD PMID:25510870 Cyp2b9 Mouse 2,2',5,5'-tetrachlorobiphenyl multiple interactions EXP 6480464 [2 more ... CTD PMID:25510870 Cyp2b9 Mouse 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CYP2B9 mRNA CTD PMID:21570461 and PMID:28922406 Cyp2b9 Mouse 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CYP2B9 gene] CTD PMID:28213091 Cyp2b9 Mouse 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP2B9 mRNA CTD PMID:28213091 Cyp2b9 Mouse 3-methylcholanthrene increases expression EXP 6480464 Methylcholanthrene results in increased expression of CYP2B9 mRNA CTD PMID:30503582 Cyp2b9 Mouse 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of CYP2B9 mRNA CTD PMID:18648102 Cyp2b9 Mouse 4,4'-sulfonyldiphenol affects expression EXP 6480464 bisphenol S affects the expression of CYP2B9 mRNA CTD PMID:31683443 Cyp2b9 Mouse Acetyl tributyl citrate increases expression EXP 6480464 2-acetyltributylcitrate results in increased expression of CYP2B9 mRNA CTD PMID:37055963 Cyp2b9 Mouse andrographolide multiple interactions EXP 6480464 [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of CYP2B9 mRNA CTD PMID:19737545 Cyp2b9 Mouse andrographolide increases expression EXP 6480464 andrographolide results in increased expression of CYP2B9 mRNA CTD PMID:19737545 Cyp2b9 Mouse androst-4-ene-3,17-dione increases expression EXP 6480464 Androstenedione results in increased expression of CYP2B9 mRNA CTD PMID:7771797 Cyp2b9 Mouse arsane increases expression EXP 6480464 Arsenic results in increased expression of CYP2B9 mRNA CTD PMID:15026472 Cyp2b9 Mouse arsenic atom increases expression EXP 6480464 Arsenic results in increased expression of CYP2B9 mRNA CTD PMID:15026472 Cyp2b9 Mouse arsenite(3-) increases expression EXP 6480464 arsenite results in increased expression of CYP2B9 protein CTD PMID:37955338 Cyp2b9 Mouse atrazine multiple interactions EXP 6480464 [Atrazine co-treated with Chlorpyrifos co-treated with Endosulfan] results in decreased expression of CYP2B9 mRNA and lycopene affects the reaction [Atrazine results in increased expression of CYP2B9 mRNA] CTD PMID:22515965 and PMID:26775023 Cyp2b9 Mouse atrazine increases expression EXP 6480464 Atrazine results in increased expression of CYP2B9 mRNA CTD PMID:26775023 Cyp2b9 Mouse benzene decreases expression EXP 6480464 Benzene results in decreased expression of CYP2B9 mRNA CTD PMID:34624356 Cyp2b9 Mouse benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of CYP2B9 mRNA and Benzo(a)pyrene results in increased expression of CYP2B9 protein CTD PMID:21964900 and PMID:34472326 Cyp2b9 Mouse berberine multiple interactions EXP 6480464 Berberine promotes the reaction [Phenobarbital results in increased expression of CYP2B9 mRNA] and Berberine promotes the reaction [Streptozocin results in increased expression of CYP2B9 mRNA] CTD PMID:22342832 Cyp2b9 Mouse berberine increases expression EXP 6480464 Berberine results in increased expression of CYP2B9 mRNA CTD PMID:22342832 Cyp2b9 Mouse beta-naphthoflavone increases expression EXP 6480464 beta-Naphthoflavone results in increased expression of CYP2B9 mRNA CTD PMID:19737545 Cyp2b9 Mouse beta-naphthoflavone multiple interactions EXP 6480464 [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of CYP2B9 mRNA CTD PMID:19737545 Cyp2b9 Mouse bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of CYP2B9 mRNA CTD PMID:19850644 Cyp2b9 Mouse cadmium sulfate multiple interactions EXP 6480464 cadmium sulfate affects the reaction [MTF1 affects the expression of CYP2B9 mRNA] CTD PMID:16221973 Cyp2b9 Mouse captan multiple interactions EXP 6480464 [Dietary Fats co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Captan co-treated with Chlorpyrifos co-treated with thiacloprid co-treated with Thiophanate co-treated with Ziram] results in increased expression of CYP2B9 mRNA CTD PMID:32745781 Cyp2b9 Mouse carbon nanotube affects expression EXP 6480464 Nanotubes and Carbon affects the expression of CYP2B9 mRNA CTD PMID:25554681 Cyp2b9 Mouse carbon nanotube decreases expression EXP 6480464 Nanotubes and Carbon results in decreased expression of CYP2B9 mRNA CTD PMID:25620056 Cyp2b9 Mouse Chalepensin increases expression EXP 6480464 3-(alpha and alpha-dimethylallyl)psoralen results in increased expression of CYP2B9 mRNA CTD PMID:22790670 Cyp2b9 Mouse chlorpyrifos multiple interactions EXP 6480464 [Atrazine co-treated with Chlorpyrifos co-treated with Endosulfan] results in decreased expression of CYP2B9 mRNA and [Dietary Fats co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Captan co-treated with Chlorpyrifos co-treated with thiacloprid co-treated with Thiophanate co-treated with Ziram] results in increased expression of CYP2B9 mRNA CTD PMID:22515965 and PMID:32745781 Cyp2b9 Mouse cholic acid increases expression EXP 6480464 Cholic Acid results in increased expression of CYP2B9 mRNA CTD PMID:17521389 Cyp2b9 Mouse choline multiple interactions EXP 6480464 [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in increased expression of CYP2B9 mRNA and [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CYP2B9 mRNA CTD PMID:20938992 and PMID:29127188 Cyp2b9 Mouse chromium(6+) affects expression EXP 6480464 chromium hexavalent ion affects the expression of CYP2B9 mRNA CTD PMID:28472532 Cyp2b9 Mouse ciguatoxin CTX1B affects expression EXP 6480464 Ciguatoxins affects the expression of CYP2B9 mRNA CTD PMID:18353800 Cyp2b9 Mouse clofibrate multiple interactions EXP 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of CYP2B9 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CYP2B9 mRNA] CTD PMID:17585979 Cyp2b9 Mouse clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of CYP2B9 mRNA CTD PMID:11356909 Cyp2b9 Mouse cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of CYP2B9 mRNA CTD PMID:23528251 Cyp2b9 Mouse copper atom multiple interactions EXP 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of CYP2B9 mRNA CTD PMID:15467011 Cyp2b9 Mouse copper(0) multiple interactions EXP 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of CYP2B9 mRNA CTD PMID:15467011 Cyp2b9 Mouse cyproconazole increases expression EXP 6480464 cyproconazole results in increased expression of CYP2B9 mRNA CTD PMID:22334560 Cyp2b9 Mouse cyproterone increases expression EXP 6480464 Cyproterone results in increased expression of CYP2B9 mRNA CTD PMID:7771797 Cyp2b9 Mouse dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of CYP2B9 mRNA CTD PMID:7771797 Cyp2b9 Mouse dichloroacetic acid increases expression EXP 6480464 Dichloroacetic Acid results in increased expression of CYP2B9 mRNA CTD PMID:28962523 Cyp2b9 Mouse diclofenac increases expression EXP 6480464 Diclofenac results in increased expression of CYP2B9 mRNA CTD PMID:26934552 Cyp2b9 Mouse elemental selenium increases expression EXP 6480464 Selenium deficiency results in increased expression of CYP2B9 mRNA CTD PMID:16170372 Cyp2b9 Mouse endosulfan multiple interactions EXP 6480464 [Atrazine co-treated with Chlorpyrifos co-treated with Endosulfan] results in decreased expression of CYP2B9 mRNA CTD PMID:22515965 Cyp2b9 Mouse epoxiconazole increases expression EXP 6480464 epoxiconazole results in increased expression of CYP2B9 mRNA CTD PMID:22334560 and PMID:23970803 Cyp2b9 Mouse epoxiconazole decreases expression EXP 6480464 epoxiconazole results in decreased expression of CYP2B9 mRNA CTD PMID:35436446 Cyp2b9 Mouse estrone increases expression EXP 6480464 Estrone results in increased expression of CYP2B9 mRNA CTD PMID:7771797 Cyp2b9 Mouse ethanol increases expression EXP 6480464 Ethanol results in increased expression of CYP2B9 mRNA CTD PMID:19167417 Cyp2b9 Mouse fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of CYP2B9 mRNA CTD PMID:11798191 Cyp2b9 Mouse folic acid multiple interactions EXP 6480464 [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in increased expression of CYP2B9 mRNA and [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CYP2B9 mRNA CTD PMID:20938992 and PMID:29127188 Cyp2b9 Mouse griseofulvin affects expression EXP 6480464 Griseofulvin affects the expression of CYP2B9 mRNA CTD PMID:12735108 Cyp2b9 Mouse kojic acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CYP2B9 mRNA CTD PMID:17917374 Cyp2b9 Mouse L-ascorbic acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CYP2B9 mRNA CTD PMID:17917374 Cyp2b9 Mouse L-methionine multiple interactions EXP 6480464 [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in increased expression of CYP2B9 mRNA and [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CYP2B9 mRNA CTD PMID:20938992 and PMID:29127188 Cyp2b9 Mouse lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of CYP2B9 mRNA CTD PMID:21335049 Cyp2b9 Mouse lycopene multiple interactions EXP 6480464 lycopene affects the reaction [Atrazine results in increased expression of CYP2B9 mRNA] CTD PMID:26775023 Cyp2b9 Mouse mercury dichloride increases expression EXP 6480464 Mercuric Chloride results in increased expression of CYP2B9 mRNA CTD PMID:24472606 Cyp2b9 Mouse metformin multiple interactions EXP 6480464 Metformin promotes the reaction [Streptozocin results in increased expression of CYP2B9 mRNA] CTD PMID:22342832 Cyp2b9 Mouse monocrotaline multiple interactions EXP 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of CYP2B9 mRNA CTD PMID:21224054 Cyp2b9 Mouse monosodium L-glutamate increases expression EXP 6480464 Sodium Glutamate results in increased expression of CYP2B9 mRNA CTD PMID:19001666 and PMID:20111022 Cyp2b9 Mouse monosodium L-glutamate multiple interactions EXP 6480464 [Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of CYP2B9 mRNA and [Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of CYP2B9 mRNA CTD PMID:19001666 and PMID:20111022 Cyp2b9 Mouse N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CYP2B9 mRNA and [Diethylnitrosamine co-treated with Piperonyl Butoxide] results in increased expression of CYP2B9 mRNA CTD PMID:17917374 and PMID:19690152 Cyp2b9 Mouse N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of CYP2B9 mRNA CTD PMID:24535843 Cyp2b9 Mouse nickel sulfate decreases expression EXP 6480464 nickel sulfate results in decreased expression of CYP2B9 mRNA CTD PMID:16100012 Cyp2b9 Mouse paracetamol multiple interactions EXP 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of CYP2B9 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CYP2B9 mRNA] CTD PMID:17585979 Cyp2b9 Mouse PCB138 multiple interactions EXP 6480464 [2 more ... CTD PMID:25510870 Cyp2b9 Mouse perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CYP2B9 mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of CYP2B9 mRNA CTD PMID:36331819 Cyp2b9 Mouse perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of CYP2B9 mRNA CTD PMID:18281256 Cyp2b9 Mouse perfluorooctanoic acid multiple interactions EXP 6480464 PPARA protein promotes the reaction [perfluorooctanoic acid results in increased expression of CYP2B9 mRNA] CTD PMID:18281256 Cyp2b9 Mouse phenobarbital multiple interactions EXP 6480464 Berberine promotes the reaction [Phenobarbital results in increased expression of CYP2B9 mRNA] and NR1I3 protein affects the reaction [Phenobarbital results in increased expression of CYP2B9 mRNA] CTD PMID:19482888 and PMID:22342832 Cyp2b9 Mouse phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of CYP2B9 protein CTD PMID:35881160 Cyp2b9 Mouse phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of CYP2B9 mRNA CTD PMID:14570766 more ... Cyp2b9 Mouse phenytoin increases expression EXP 6480464 Phenytoin results in increased expression of CYP2B9 protein CTD PMID:19226368 and PMID:19903449 Cyp2b9 Mouse phenytoin multiple interactions EXP 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of CYP2B9 mRNA CTD PMID:21224054 Cyp2b9 Mouse piperonyl butoxide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Piperonyl Butoxide] results in increased expression of CYP2B9 mRNA CTD PMID:19690152 Cyp2b9 Mouse piperonyl butoxide increases expression EXP 6480464 Piperonyl Butoxide results in increased expression of CYP2B9 mRNA CTD PMID:17014948 and PMID:19690152 Cyp2b9 Mouse pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of CYP2B9 mRNA CTD PMID:11798191 more ... Cyp2b9 Mouse potassium dichromate increases expression EXP 6480464 Potassium Dichromate results in increased expression of CYP2B9 mRNA CTD PMID:23608068 Cyp2b9 Mouse pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of CYP2B9 mRNA CTD PMID:27413110 and PMID:28903501 Cyp2b9 Mouse progesterone increases expression EXP 6480464 Progesterone results in increased expression of CYP2B9 mRNA CTD PMID:7771797 Cyp2b9 Mouse propiconazole increases expression EXP 6480464 propiconazole results in increased expression of CYP2B9 mRNA CTD PMID:22334560 and PMID:23970803 Cyp2b9 Mouse quercetin multiple interactions EXP 6480464 [Dietary Fats co-treated with Quercetin] affects the expression of CYP2B9 mRNA CTD PMID:25047408 Cyp2b9 Mouse resveratrol multiple interactions EXP 6480464 Resveratrol inhibits the reaction [Dietary Fats affects the expression of CYP2B9 mRNA] and Resveratrol inhibits the reaction [titanium dioxide results in increased expression of CYP2B9 mRNA] CTD PMID:17086191 and PMID:31298478 Cyp2b9 Mouse rifampicin multiple interactions EXP 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of CYP2B9 mRNA CTD PMID:21224054 Cyp2b9 Mouse rifampicin decreases expression EXP 6480464 Rifampin results in decreased expression of CYP2B9 mRNA CTD PMID:30503582 Cyp2b9 Mouse selenium atom increases expression EXP 6480464 Selenium deficiency results in increased expression of CYP2B9 mRNA CTD PMID:16170372 Cyp2b9 Mouse sodium arsenite affects expression EXP 6480464 sodium arsenite affects the expression of CYP2B9 mRNA CTD PMID:16507464 Cyp2b9 Mouse sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of CYP2B9 mRNA CTD PMID:11353140 and PMID:17350061 Cyp2b9 Mouse sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of CYP2B9 mRNA CTD PMID:25065748 Cyp2b9 Mouse streptozocin multiple interactions EXP 6480464 [Streptozocin co-treated with Dietary Fats] results in increased expression of CYP2B9 mRNA more ... CTD PMID:22342832 and PMID:29127188 Cyp2b9 Mouse streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of CYP2B9 mRNA CTD PMID:22342832 Cyp2b9 Mouse tamoxifen increases expression EXP 6480464 Tamoxifen results in increased expression of CYP2B9 mRNA CTD PMID:7771797 Cyp2b9 Mouse tert-butanol increases expression EXP 6480464 tert-Butyl Alcohol results in increased expression of CYP2B9 mRNA CTD PMID:19760798 Cyp2b9 Mouse testosterone decreases expression EXP 6480464 Testosterone results in decreased expression of CYP2B9 mRNA CTD PMID:20844152 and PMID:21669218 Cyp2b9 Mouse testosterone affects expression EXP 6480464 Testosterone affects the expression of CYP2B9 mRNA CTD PMID:7771797 Cyp2b9 Mouse Testosterone propionate affects expression EXP 6480464 Testosterone Propionate affects the expression of CYP2B9 CTD PMID:20943812 Cyp2b9 Mouse tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of CYP2B9 mRNA CTD PMID:29987408 Cyp2b9 Mouse tetrahydrocurcumin decreases expression EXP 6480464 tetrahydrocurcumin results in decreased expression of CYP2B9 mRNA CTD PMID:26102010 Cyp2b9 Mouse thiacloprid multiple interactions EXP 6480464 [Dietary Fats co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Captan co-treated with Chlorpyrifos co-treated with thiacloprid co-treated with Thiophanate co-treated with Ziram] results in increased expression of CYP2B9 mRNA CTD PMID:32745781 Cyp2b9 Mouse thiophanate-methyl multiple interactions EXP 6480464 [Dietary Fats co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Captan co-treated with Chlorpyrifos co-treated with thiacloprid co-treated with Thiophanate co-treated with Ziram] results in increased expression of CYP2B9 mRNA CTD PMID:32745781 Cyp2b9 Mouse titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of CYP2B9 mRNA CTD PMID:23557971 Cyp2b9 Mouse titanium dioxide multiple interactions EXP 6480464 Resveratrol inhibits the reaction [titanium dioxide results in increased expression of CYP2B9 mRNA] CTD PMID:31298478 Cyp2b9 Mouse titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of CYP2B9 mRNA CTD PMID:31298478 and PMID:31769605 Cyp2b9 Mouse toxaphene increases expression EXP 6480464 Toxaphene results in increased expression of CYP2B9 mRNA CTD PMID:28218408 Cyp2b9 Mouse toxaphene multiple interactions EXP 6480464 NR1I3 gene mutant form inhibits the reaction [Toxaphene results in increased expression of CYP2B9 mRNA] CTD PMID:28218408 Cyp2b9 Mouse valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of CYP2B9 mRNA CTD PMID:17963808 Cyp2b9 Mouse valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of CYP2B9 mRNA CTD PMID:24489787 Cyp2b9 Mouse ziram multiple interactions EXP 6480464 [Dietary Fats co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Captan co-treated with Chlorpyrifos co-treated with thiacloprid co-treated with Thiophanate co-treated with Ziram] results in increased expression of CYP2B9 mRNA CTD PMID:32745781
